Browse Submissions By Project
| Project | View Details |
|---|---|
|
AB-DME
TaqMan Drug Metabolism SNP Genotyping Assays
Principal Investigator: Xiaoqing You |
|
|
APP
Autonomic Pharmacodynamic Pharmacogenomics
Principal Investigator: Daniel T. O'Connor |
|
|
BARGA
Beta Adrenergic Receptor Genotypes and Asthma
Principal Investigator: Richard Judson |
|
|
CIA
Pharmacogenetics of CYP Inhibition and Activation
Principal Investigator: Timothy Scott Tracy |
|
|
COBRA
Consortium on Breast Cancer Pharmacogenomics
Principal Investigator: David A. Flockhart |
|
|
COL
Linking Collagen Genotypes to Molecular Phenotypes
Principal Investigator: Teri E. Klein |
|
|
CREATE
Functional Polymorphism Analysis in Drug Pathways
Principal Investigator: Howard Lawrence McLeod |
|
|
GERA
Genetic Epidemiology of Responses to Antihypertensives
Principal Investigator: Stephen T. Turner, M.D. |
|
|
GOFMOP
Genetics of Folate Modulation of Phenotype
Principal Investigator: Alexander S. Whitehead |
|
|
GOH
Genetics of Opioid Induced Hyperalgesia
Principal Investigator: David Clark |
|
|
IN-RANGE
Predictors of Anticoagulation Control on Warfarin
Principal Investigator: Dr. Stephen E Kimmel |
|
|
INVEST
INternational VErapamil-trandolapril STudy
Principal Investigator: Julie A. Johnson |
|
|
IWPC
Pharmacogenomics of Warfarin Dosing
|
|
|
LDCHRS
The linkage disequilibrium maps of three human chromosomes across four populations
Principal Investigator: Dr. Francisco M De La Vega |
|
|
MGHB
Molecular Genetics of Human Behavior
Principal Investigator: Charles Glatt |
|
|
NATPG
Pharmacogenetics of NAT and Sulfonamide Toxicity
Principal Investigator: Craig Karl Svensson |
|
|
NPC1L1
Niemann-Pick C1-like 1
Principal Investigator: Dr. Jason S Simon |
|
|
Non-Network
Non-Network / Other
|
|
|
PAAR
Pharmacogenetics of Anticancer Agents - University of Chicago
Principal Investigator: Mark J. Ratain |
|
|
PAM
Pharmacogenetics of Asthma Monotherapy
Principal Investigator: John Joseph Lima PharmD |
|
|
PAPI
The Amish Pharmacogenomics of Anti-Platelet Intervention Study
Principal Investigator: Dr. Alan Rodney Shuldiner |
|
|
PARC
Pharmacogenomics and Risk of Cardiovascular Disease
Principal Investigator: Ronald M. Krauss |
|
|
PAT
Pharmacogenomics of Arrhythmia Therapy
Principal Investigator: Dan Mark Roden |
|
|
PBAT
Pharmacogenetics, Biomarkers, and Antithrombotic Therapy
Principal Investigator: Brian F. Gage |
|
|
PCE
Pharmacogenetics and Cardiovascular Events
Principal Investigator: Dr. Bruce M Psaty |
|
|
PEAR
Pharmacogenomic Evaluation of Antihypertensive
Principal Investigator: Julie A. Johnson |
|
|
PFMO
Pharmacogenetics of FMO
Principal Investigator: Ronald N. Hines |
|
|
PGSR
Pharmacogenetics of the Statin Response
Principal Investigator: Dr. Ernst John Schaefer |
|
|
PHAT
Pharmacogenetics of Asthma Treatment
Principal Investigator: Scott T. Weiss |
|
|
PHAT-PAM
Pharmacogenetics of Asthma Treatment/Pharmacogenetics of Asthma Monotherapy
Principal Investigator: John Joseph Lima PharmD |
|
|
PMOR
Pharmacodynamics of the mu Opioid Receptor
Principal Investigator: Mary Jeanne Kreek |
|
|
PMT
Pharmacogenetics of Membrane Transporters
Principal Investigator: Kathleen M. Giacomini |
|
|
PNAT
Pharmacogenetics of Nicotine Addiction and Treatment
Principal Investigator: Dr. Neal Benowitz |
|
|
PPII
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Principal Investigator: Richard M. Weinshilboum |
|
|
PPRG
UCLA Pharmacogenetics and Pharmacogenomics Research Group
Principal Investigator: Julio Licinio |
|
|
RISC
Relative Impact of SNPs and Covariates
Principal Investigator: Russell Alan Wilke |
|
|
UM-ALL
Pharmacogenetics of Acute Lymphoblastic Leukemia
Principal Investigator: Maja Krajinovic |
|
Submitters with literature annotations only are not listed.